Beovu & Recarbrio Among Five Drugs On Track For EU-Wide Approval
No Decision On Celgene/Agios Pharmaceuticals’ AML Drug Enasidenib
Executive Summary
Five new drugs have been recommended for EU approval at the latest meeting of European Medicines Agency’s drug evaluation committee.
You may also be interested in...
2019 Sees Decline In EMA Drug Approval Recommendations
The number of positive opinions given by the EMA’s CHMP has fallen to 66 this year from 84 in 2018.
EMA Prepares Approval Verdict On Beovu, Idhifa, Recarbrio
Products from Novartis, Celgene and Merck could get an EU approval recommendation at this week's CHMP meeting.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.